Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine.

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

CLASSIC enables large-scale testing of complex DNA circuits in human cells, advancing data-driven synthetic biology.

At a recent major industry event, Hyundai and Boston Dynamics took the wraps off its next-gen humanoid robot that is nearly ...

Tracking outbreaks, classifying novel microorganisms, and researching microbiomes has never been more prominent. Next-generation sequencing has become an i | Ebooks ...

The next major evolution will come from multi-agent systems—networks of smaller, specialized AI models that coordinate across ...

Silex Systems develops the laser-based isotope separation technology, which could be valuable for the U.S. nuclear ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.